FGFR2 and cervical squamous intraepithelial neoplasia: Moreover in the TCGA dataset almost 9% of patients within the CIN subtype presented FGFR2 gene amplification, which convinced researchers to test the FGFR inhibitors in FGFR2 amplified GC.